From arteries to capillaries: approaches to engineering human vasculature
- PMID: 33708027
- PMCID: PMC7942836
- DOI: 10.1002/adfm.201910811
From arteries to capillaries: approaches to engineering human vasculature
Abstract
From micro-scaled capillaries to millimeter-sized arteries and veins, human vasculature spans multiple scales and cell types. The convergence of bioengineering, materials science, and stem cell biology has enabled tissue engineers to recreate the structure and function of different hierarchical levels of the vascular tree. Engineering large-scale vessels has been pursued over the past thirty years to replace or bypass damaged arteries, arterioles, and venules, and their routine application in the clinic may become a reality in the near future. Strategies to engineer meso- and microvasculature have been extensively explored to generate models to study vascular biology, drug transport, and disease progression, as well as for vascularizing engineered tissues for regenerative medicine. However, bioengineering of large-scale tissues and whole organs for transplantation, have failed to result in clinical translation due to the lack of proper integrated vasculature for effective oxygen and nutrient delivery. The development of strategies to generate multi-scale vascular networks and their direct anastomosis to host vasculature would greatly benefit this formidable goal. In this review, we discuss design considerations and technologies for engineering millimeter-, meso-, and micro-scale vessels. We further provide examples of recent state-of-the-art strategies to engineer multi-scale vasculature. Finally, we identify key challenges limiting the translation of vascularized tissues and offer our perspective on future directions for exploration.
Keywords: Tissue engineering; engineered microvasculature; tissue engineered blood vessels; tissue vascularization.
Conflict of interest statement
Conflict of interest The authors declare no conflict of interest.
Figures
References
-
- Weinberg CB, Bell E, Science 1986, 231, 397; - PubMed
- L’heureux N, Pâquet S, Labbé R, Germain L, Auger FA, The FASEB Journal 1998, 12, 47; - PubMed
- Walpoth BH, Bowlin GL, Expert Review of Medical Devices 2005, 2, 647; - PubMed
- Matsumura G, Isayama N, Matsuda S, Taki K, Sakamoto Y, Ikada Y, Yamazaki K, Biomaterials 2013, 34, 6422; - PubMed
- Kirkton RD, Santiago-Maysonet M, Lawson JH, Tente WE, Dahl SL, Niklason LE, Prichard HL, Science translational medicine 2019, 11, eaau6934. - PMC - PubMed
-
- Qiu Y, Ahn B, Sakurai Y, Hansen CE, Tran R, Mimche PN, Mannino RG, Ciciliano JC, Lamb TJ, Joiner CH, Nature biomedical engineering 2018, 2, 453; - PMC - PubMed
- Song JW, Munn LL, Proceedings of the National Academy of Sciences 2011, 108, 15342; - PMC - PubMed
- Calderon G, Thai P, Hsu C, Grigoryan B, Gibson S, Dickinson M, Miller J, Biomaterials science 2017, 5, 1652; - PubMed
- Hsu Y-H, Moya ML, Hughes CC, George SC, Lee AP, Lab on a chip 2013, 13, 2990. - PMC - PubMed
-
- Hinton TJ, Jallerat Q, Palchesko RN, Park JH, Grodzicki MS, Shue H-J, Ramadan MH, Hudson AR, Feinberg AW, Science advances 2015, 1, e1500758; - PMC - PubMed
- Noor N, Shapira A, Edri R, Gal I, Wertheim L, Dvir T, Advanced Science 2019, 1900344; - PMC - PubMed
- Zohar B, Blinder Y, Mooney DJ, Levenberg S, ACS Biomaterials Science & Engineering 2017, 4, 1265; - PubMed
- Brandenberg N, Lutolf MP, Advanced Materials 2016, 28, 7450. - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous